Subscribe To
Biovie presents alzheimer's study data on patient's baseline characteristics
BioVie Inc (NASDAQ:BIVI) has unveiled early data from its Phase 3 study of its investigational drug NE3107 in patients with mild to moderate ...
September 11, 2023, 8:42 am
Alector (alec) up 7% on finishing enrolment in alzheimer study
Alector (ALEC) completes enrolment in a mid-stage study evaluating its investigational monoclonal antibody in patients with early ...
September 8, 2023, 1:32 pm
Circular genomics announces partnership on alzheimer’s disease biomarker research
Albuquerque, NM, Sept. 06, 2023 (GLOBE NEWSWIRE) — Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry, has ann...
September 6, 2023, 9:24 pm
Promis neurosciences to present at the h.c. wainwright 25th annual global investment conference
TORONTO, Ontario and CAMBRIDGE, Massachusetts, Sept. 06, 2023 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company foc...
September 6, 2023, 12:18 pm
Tiziana life sciences highlights publication of promising intranasal foralumab in alzheimer's study results
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said a study validating the mechanism of action of its drug candidate intranasal foralumab in ...
September 6, 2023, 9:33 am
Biogen's (biib) stock outperforms industry ytd: here's why
While most of Biogen's (BIIB) key drugs are facing declining sales, new products, like Leqembi in alzheimer...
September 5, 2023, 11:18 am
Here's 1 stock that could join apple and amazon in the $1 trillion club that you might have overlooked
Unlike the current five stocks with $1 trillion market caps, AI isn't a major factor for this contender. Instead, its fortunes rely largely on treatin...
September 5, 2023, 9:12 am
Karuna's robust liquidity paves way for karxt milestones (rating upgrade)
Karuna Therapeutics develops innovative treatments for psychiatric and neurological disorders, with their investigational drug KarXT targeting schizop...
August 16, 2023, 5:08 pm
Ge healthcare is an alzheimer's stock. shares are rising.
Wells Fargo analyst Larry Biegelsen launched coverage of GE HealthCare Technologies stock with a Buy rating and a $90 price target....
August 16, 2023, 8:41 am
Tiziana life sciences shares skyrocket after fda greenlights intranasal foralumab for alzheimer's disease
Tiziana Life Sciences Ltd (NASDAQ:TLSA) shares added almost 55% in pre-market trading on Tuesday after the biotechnology company announced that its In...
August 15, 2023, 9:04 am
Tiziana life sciences' stock soars 41% premarket after fda clear path for trial of intranasal treatment for alzheimer's disease
Tiziana Life Sciences Ltd.'s stock TLSA soared 41% in premarket trade Tuesday, after the microcap biotech said it has received clearance from Food and...
August 15, 2023, 7:29 am
More alzheimer's treatments are coming: this company can help with early detection
Biogen and Eli Lilly both have treatments to help reduce cognitive decline in alzheimer's patients. But...
August 9, 2023, 9:53 am
Eli lilly has a big stake in weight loss and alzheimer's drugs; but is the stock a buy?
Eli Lilly surged 15% in one day on enthusiasm for weight-loss and alzheimer's drugs. But is LLY stock a...
August 9, 2023, 8:00 am
Ai, alzheimer's, and margins: how ge healthcare is preparing for growth
GE Healthcare is suffering near-term margin pressure, but much of it is for reasons that will lead to revenue growth and margin growth in the future. ...
August 8, 2023, 10:25 am
Eli lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%
Eli Lilly's stock has been on a tear, driven by positive trial results for its alzheimer's drug and pro...
August 8, 2023, 7:04 am
Anavex life sciences reports publication of anavex®3-71 in clinical journal confirming anavex®3-71 clinical cardiovascular safety
NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharma...
August 7, 2023, 11:30 am
Anavex life sciences to announce fiscal 2023 third quarter financial results on tuesday august 8, 2023
Webcast and Conference Call To be Held Tuesday, August 8, 2023, 8:30 am ET NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (�...
August 1, 2023, 11:30 am
Better alzheimer's drug stock: eli lilly vs. biogen
Biogen and Eli Lilly are two major competitors in the field of alzheimer's disease. Eli Lilly's medicin...
July 31, 2023, 7:45 am
Quest diagnostics launches first at-home blood test to assess risk of developing alzheimer's disease
Quest Diagnostics Inc. DGX, +0.10% said Monday it has brought the first blood-based biomarker test to assess the risk of developing ...
July 31, 2023, 7:23 am
Quest diagnostics launches alzheimer's blood test for consumers
Quest Diagnostics on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key ...
July 31, 2023, 7:10 am